Transglutaminases and Obesity in Humans: Association of F13A1 to Adipocyte Hypertrophy and Adipose Tissue Immune Response

Mari T. Kaartinen, Mansi Arora, Sini Heinonen, Aila Rissanen, Jaakko Kaprio, Kirsi H. PietiläinenInternational Journal of Molecular Sciences 2020 · DOI

TL;DR

This study investigates the role of transglutaminases (TGs) in human obesity, specifically focusing on their association with enlarged fat cells (adipocyte hypertrophy) and the resulting inflammatory response. They found that the gene F13A1, which codes for a specific TG, is significantly upregulated in the adipose tissue of heavier individuals within weight-discordant twin pairs, and this upregulation is linked to genes involved in immune activation and inflammation.

What Problem Does This Paper Address?

Obesity is a complex metabolic disorder strongly linked to chronic low-grade inflammation in adipose tissue. While large fat cells (hypertrophic adipocytes) are a hallmark of obesity and are associated with worse metabolic outcomes, the precise molecular mechanisms connecting adipocyte expansion to inflammation are not fully understood. Transglutaminases (TGs) are a family of enzymes known to play roles in various cellular processes, and recent research has hinted at their involvement in adipose tissue biology and obesity. However, human studies specifically examining the role of TGs within adipocytes in the context of weight gain and hypertrophy were lacking. This paper aims to fill that gap by investigating the entire TG gene family in human adipose tissue from individuals with varying body weights, with a particular focus on understanding how F13A1 might contribute to the inflammatory consequences of adipocyte hypertrophy.

Methods

The researchers utilized a multi-pronged approach:

  • Twin Study Design: They analyzed adipose tissue and adipocyte-enriched fractions from monozygotic (MZ) twin pairs who were discordant for body weight. MZ twins share nearly identical genetics, making them ideal for studying the effects of environmental factors like weight gain.
  • Gene Expression Analysis: They measured the mRNA expression levels of all nine transglutaminase (TGM) family genes in both adipose tissue and adipocyte-enriched fractions from the heavier and leaner co-twins.
  • Transcriptome-Wide Association Study (TWAS): This technique was used to identify genes whose expression patterns were significantly correlated with both F13A1 expression and adipocyte size in the weight-discordant twins.
  • Gene Enrichment Analysis: They employed GOnet and Panther tools to analyze the functions of the genes identified through TWAS, looking for over-represented biological processes and cellular components. This helps to understand the pathways and cellular activities associated with the observed gene expression changes.
  • Correlation Analysis: Statistical methods, including ANOVA and Pearson correlation, were used to quantify the relationships between gene expression, weight, and adipocyte size.

Datasets

The study utilized adipose tissue biopsies from 12 pairs of weight-discordant monozygotic twins. These twins were identified from two population-based twin cohorts (FinnTwin16 and FinnTwin12). The clinical characteristics of these twin pairs, including weight, BMI, body fat percentage, and adipocyte diameter, were previously characterized and are presented in the paper.

Key Insights and Ideas

  • F13A1 as a Key Player: The study strongly implicates F13A1 as the sole transglutaminase gene significantly upregulated in response to acquired excess weight in human adipose tissue. This suggests a specific role for this enzyme in the adaptive or maladaptive responses to weight gain.
  • Link to Hypertrophy and Inflammation: The increased expression of F13A1 in heavier individuals was not just a general response to weight gain but was specifically associated with genes involved in adipocyte size and, crucially, with pathways related to immune response, neutrophil activation, and cytokine signaling.
  • Adipocytes as Immune Modulators: The findings suggest that hypertrophic adipocytes, influenced by F13A1, may actively participate in initiating and perpetuating inflammation, potentially by signaling to immune cells like neutrophils.
  • Complex Network of Interactions: The gene enrichment analysis revealed that F13A1 is connected to a network of genes involved in various aspects of immune response, including cellular activation, secretion, and response to external stimuli like lipopolysaccharides (LPS).

Key Results

  • F13A1 was the only TGM family gene showing significantly increased expression in the adipose tissue and adipocyte-enriched fraction of the heavier twin in weight-discordant MZ pairs.
  • Differential expression of F13A1 (∆Heavy-Lean) was significantly correlated with 47 genes that are also associated with large adipocyte size.
  • Gene enrichment analysis of these 47 genes revealed strong links to biological processes such as immune response, neutrophil activation, and cytokine signaling.
  • Specific genes identified in this network included PYCARD (involved in inflammasome activation), IL1B (an early pro-inflammatory cytokine), and HLA-DRA (involved in antigen presentation).

Limitations and Future Work

The authors acknowledge that the adipocyte-enriched fraction used in their study, while enriched for adipocytes, may still contain other cell types (e.g., pre-adipocytes, immune cells). This means that some of the observed gene expression changes might originate from these co-purified cells. Future work is planned to detail the specific cell types responsible for F13A1 production and activation in adipose tissue during different phases of expansion. The study also raises questions about the precise stimuli that initiate F13A1 production and its activation mechanisms. Further investigations into the role of F13A1 in weight gain and its consequences, including studies on the absence or overexpression of F13A1 in animal models, are ongoing and aim to explore F13A1 as a potential target for controlling adipose tissue inflammation.

Summary updated

Abstract

Transglutaminases TG2 and FXIII-A have recently been linked to adipose tissue biology and obesity, however, human studies for TG family members in adipocytes have not been conducted. In this study, we investigated the association of <i>TGM</i> family members to acquired weight gain in a rare set of monozygotic (MZ) twins discordant for body weight, i.e., heavy-lean twin pairs. We report that <i>F13A1</i> is the only <i>TGM</i> family member showing significantly altered, higher expression in adipose tissue of the heavier twin. Our previous work linked adipocyte <i>F13A1</i> to increased weight, body fat mass, adipocyte size, and pro-inflammatory pathways. Here, we explored further the link of <i>F13A1</i> to adipocyte size in the MZ twins via a previously conducted TWA study that was further mined for genes that specifically associate to hypertrophic adipocytes. We report that differential expression of <i>F13A1</i> (ΔHeavy-Lean) associated with 47 genes which were linked via gene enrichment analysis to immune response, leucocyte and neutrophil activation, as well as cytokine response and signaling. Our work brings further support to the role of <i>F13A1</i> in the human adipose tissue pathology, suggesting a role in the cascade that links hypertrophic adipocytes with inflammation.
BibTeX
@article{kaartinen2020transglutaminases,
  author = {Mari T. Kaartinen and Mansi Arora and Sini Heinonen and Aila Rissanen and Jaakko Kaprio and Kirsi H. Pietiläinen},
  title = {{Transglutaminases and Obesity in Humans: Association of F13A1 to Adipocyte Hypertrophy and Adipose Tissue Immune Response}},
  journal = {International Journal of Molecular Sciences},
  year = {2020},
  doi = {10.3390/ijms21218289},
}
Figure